Letrozole as a Prophylaxis From GTN for Complete Mole Patients
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Prophylactic use of aromatase inhibitor is effective in decreasing the incidence of
Gestational Trophoblastic Neoplasia (GTN) in patients with complete hydatidiform mole (CHM)